Welcome to our dedicated page for Turning Pt Brands SEC filings (Ticker: TPB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Turning Point Brands, Inc. (NYSE: TPB) SEC filings page provides direct access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Delaware-incorporated manufacturer, marketer and distributor of Other Tobacco Products and modern oral nicotine products, Turning Point Brands uses these filings to report its financial condition, segment performance and material corporate events.
Core periodic reports such as the Form 10-K annual report and Form 10-Q quarterly reports contain detailed information on Zig-Zag and Stoker’s segment results, Modern Oral net sales, gross profit, liquidity, debt structure and risk factors related to tobacco and nicotine regulation. Investors can review how the company presents non-GAAP measures like Adjusted EBITDA and Adjusted Net Income alongside GAAP results, with reconciliations included in the filings or attached exhibits.
Current reports on Form 8-K document significant events, including quarterly earnings releases, changes to at-the-market equity offering programs, and other corporate actions. For example, TPB has filed 8-Ks describing its second and third quarter results and amendments to its ATM prospectus supplement, as well as legal opinions related to additional common stock that may be sold under its shelf registration statement.
Users can also monitor Form 4 insider transaction reports, proxy statements on Schedule 14A and other specialized forms to understand executive and director share activity, governance matters and compensation policies. Real-time updates from EDGAR ensure that new filings appear promptly, while AI-powered summaries help explain complex documents, highlight key figures and clarify segment trends so readers can navigate lengthy reports more efficiently.
Whether you are researching TPB’s Modern Oral growth, its capital structure, or the regulatory environment for its tobacco and nicotine products, this filings page serves as a centralized resource for the company’s official SEC disclosures and AI-assisted analysis.
Turning Point Brands, Inc. provides an in‑depth overview of its 2025 business in this annual report, highlighting two core segments: Zig‑Zag rolling papers and accessories, and Stoker’s moist snuff and chewing tobacco. The company emphasizes asset‑light manufacturing, with about 75% of 2025 net sales from outsourced production, supporting strong free cash flow and relatively low capital spending.
Management reports exposure to growing cannabinoid consumption through Zig‑Zag accessories, while noting that tobacco products still represented roughly 62% of 2025 net sales. On January 2, 2025, the former Creative Distribution Solutions segment was contributed to a joint venture and is now treated as discontinued operations. As of June 30, 2025, non‑affiliate common stock held a market value of about $1.31 billion, and 19,141,208 voting common shares were outstanding as of February 23, 2026. The filing also details heavy investment—about $34.8 million to date—in FDA Premarket Tobacco Applications for a broad portfolio of noncombustible products, extensive long‑term supply and licensing arrangements for Zig‑Zag and Stoker’s, and a robust risk section covering regulation, competition, supply‑chain dependence, and shifting consumer preferences.
Turning Point Brands reported strong growth for the fourth quarter and full year 2025. Full-year net sales rose to $463.1 million from $360.7 million, with gross profit increasing to $264.3 million. Net income attributable to the company improved to $58.2 million, and diluted EPS reached $3.11, up from $2.14.
In Q4 2025, net sales grew to $121.0 million from $93.7 million, while net income attributable to the company climbed to $8.2 million from $2.4 million. Adjusted EBITDA for the quarter increased to $30.0 million, and full-year Adjusted EBITDA rose to $119.5 million.
Stoker’s segment was the main growth driver, with Q4 net sales of $81.0 million and full-year net sales of $284.6 million, both up sharply, supported by triple-digit Modern Oral growth. Zig-Zag segment net sales declined to $40.0 million in Q4 and $178.5 million for 2025 as the company wound down the Clipper business.
Cash generation and the balance sheet strengthened. Cash at December 31, 2025 was $222.8 million, net debt was $77.2 million, and total liquidity was $290.1 million. For 2026, management expects Modern Oral gross revenue of $220–$240 million, net revenue of $180–$190 million, and Q1 2026 Adjusted EBITDA of $24–$27 million, reflecting continued investment in Modern Oral brands.
Divisadero Street Capital Management, LP and related entities filed an amended Schedule 13G reporting a passive stake in Turning Point Brands, Inc. common stock. They report beneficial ownership of 531,214 shares, or 2.8% of the class as of the stated event date.
Divisadero Street Partners, L.P. and its general partner each report beneficial ownership of 341,597 shares, or 1.8% of the class. All securities are directly owned by advisory clients of Divisadero Street Capital Management, LP, and each reporting person disclaims beneficial ownership beyond its pecuniary interest. The filing certifies the holdings are not for the purpose of changing or influencing control of Turning Point Brands.
Morgan Stanley filed an amended Schedule 13G showing its ownership in Turning Point Brands, Inc. common stock at 325,188 shares, representing 1.7% of the class as of December 31, 2025. Morgan Stanley reports zero sole voting or dispositive power, with all reported authority shared.
The filing states that, as of this date, Morgan Stanley has ceased to be the beneficial owner of more than five percent of Turning Point Brands’ common stock. It also certifies the position is held in the ordinary course of business and not for the purpose of influencing control of the company.
Turning Point Brands, Inc. director files Form 4 for routine tax withholding. On January 2, 2026, a director reported a transaction in common stock coded "F," indicating 425 shares were withheld at $110.24 per share to cover taxes on restricted stock units that vested on that date. This was not an open-market buy or sell but a share withholding for tax purposes.
After this transaction, the director beneficially owned 283,291 shares, consisting of 281,086 shares of common stock and 2,205 restricted stock units. The filing also lists multiple option awards under the company’s 2015 Equity Incentive Plan, with exercise prices ranging from $14.85 to $51.75 and expiration dates between May 17, 2027 and February 18, 2031, all held in direct ownership.
Turning Point Brands, Inc. reported an insider equity transaction for its Sr VP and General Counsel, Brittani Cushman. On 01/02/2026, 193 shares of common stock were withheld at $110.24 per share to cover taxes on restricted stock units that vested on that date. After this tax-withholding transaction, she beneficially owned 34,081 shares of common stock directly, plus 406.806 shares held indirectly by her spouse.
The filing also lists several outstanding stock option awards granted under the company’s equity incentive plans. These options cover 8,000, 7,000, 3,000, 4,800 and 500 shares of common stock at exercise prices ranging from $14.85 to $51.75, with expiration dates between 03/07/2028 and 03/14/2032, reflecting previously granted long-term compensation.
Turning Point Brands president and CEO Graham Purdy reported an equity transaction involving company stock. On January 2, 2026, 368 shares of Turning Point Brands, Inc. common stock were withheld to cover taxes due on restricted stock units that vested the same day at a price of $110.24 per share. After this tax withholding, Purdy beneficially owns 227,098 shares, consisting of 33,186 restricted stock units and 193,912 shares of common stock.
The filing also notes that on December 8, 2025, Purdy entered into a financing transaction with an unaffiliated dealer to receive approximately $12.3 million, secured by a pledge of up to 140,140 shares of Turning Point Brands common stock. Beginning on the December 10, 2026 maturity date, he must either repay the lender in cash or may deliver up to 140,140 shares at a price per share between $91.50 and $104.45, while retaining dividend and voting rights on the pledged shares.
Turning Point Brands, Inc. insider activity centers on option exercises, share sales, and a revised share-backed financing. Executive Chairman and Director David Glazek exercised 30,000 stock options at $20.71 per share and sold 30,000 shares of common stock at $110.26 per share on 12/19/2025. After these transactions, he beneficially owns 157,083 common shares, including 35,956 restricted stock units and 91,127 shares of common stock. He also holds 54,289 options with a $27.19 exercise price and 47,519 options with a $20.71 exercise price.
The filing also reports a revised financing transaction involving a forward contract on up to 78,000 pledged shares of Turning Point Brands common stock. On December 19, 2025, Glazek replaced a prior contract with a new one that reflects the current stock price and extends its duration, receiving a gross amount of approximately $7.0 million. On the revised maturity date of December 19, 2027, he must either repay the lender in cash or deliver up to 78,000 shares at prices ranging from $105.33 to $126.39 per share, depending on the market price. He retains beneficial ownership of the pledged shares, including dividend and voting rights, and the revised financing was completed at a price of $110.87 per share.
A holder of TPB common stock filed a notice of intent to sell 78,000 shares through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 12/19/2025. The securities are common shares, and there were 19,070,757 shares outstanding at the time referenced, which is a baseline figure rather than the amount being sold.
The shares to be sold come from several acquisitions: restricted stock that vested under a registered plan on 05/05/2023, 03/01/2024, and 03/11/2024, along with an open market purchase on 01/11/2024. These lots were acquired either as compensation or for cash, and this filing formally discloses the planned sale under Rule 144.
Turning Point Brands director Charles H.C. Diao reported selling 2,000 shares of common stock on 12/15/2025. The sale, coded "S" for a sale transaction, was executed at a weighted average price of $108.2, with individual trade prices ranging from $107.98 to $108.25.
Following this transaction, Diao beneficially owns 9,804 shares of Turning Point Brands, all held directly. This total includes 1,058 shares of restricted stock and 8,972 shares of common stock, reflecting his remaining equity stake after the reported sale.